These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22096973)

  • 1. [Prevention and management of hepatitis B virus reactivation during anticancer or immunosuppressive therapy].
    Oketani M; Tsubouchi H
    Nihon Rinsho; 2011 May; 69 Suppl 4():520-5. PubMed ID: 22096973
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.
    Lubel JS; Testro AG; Angus PW
    Intern Med J; 2007 Oct; 37(10):705-12. PubMed ID: 17894766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of HBV reactivation under chemotherapy and immunosuppressants].
    Belle A; Bronowicki JP
    Rev Prat; 2011 Jan; 61(1):52-4. PubMed ID: 21452543
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening practices for hepatitis B virus prior to viral reactivation risk therapies among different medical specialties. HEBRA Project].
    García-Bengoechea M; Hernández-López C; Crespo J; Gea F;
    Med Clin (Barc); 2012 Nov; 139(11):498-501. PubMed ID: 22982126
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
    Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].
    Sato K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):161-8. PubMed ID: 21368477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
    Mimura N; Tsujimura H; Ise M; Sakai C; Kojima H; Fukai K; Yokosuka O; Takagi T; Kumagai K
    Rinsho Ketsueki; 2009 Dec; 50(12):1715-9. PubMed ID: 20068280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S
    Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy and immunosuppression in patients with hepatitis B or C].
    Sitruk V; Fain O; Gordien E; Ganne-Carrié N; Deny P; Beaugrand M; Trinchet JC
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1002-7. PubMed ID: 11845054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reactivation of HBV due to immunosuppressive and/or anticancer therapies].
    Mochida S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():546-9. PubMed ID: 26845994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis, management and prevention of hepatitis B virus reactivation during anticancer therapy].
    Gui HL; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):78-80. PubMed ID: 17244474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis B tests as screenings for the reactivation of HBV infection at Fukuoka University Hospital].
    Matsuzaki T; Ohkubo K; Kawashima H; Matsunaga A
    Rinsho Byori; 2011 Jun; 59(6):559-64. PubMed ID: 21815477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL; Regev A; Schiff ER
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivation of hepatitis B in a long-term anti-HBS-positive patient after immunosuppressive therapy].
    Bizid S; Sabbah M; Ben Abdallah H; Zaaimi Y; Bouali R; Ben Othman T; Abdelli N
    Tunis Med; 2015 Jul; 93(7):483-4. PubMed ID: 26757513
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
    Mancuso A; Pagliaro L
    Am J Gastroenterol; 2002 May; 97(5):1268-9. PubMed ID: 12014746
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management for reactivation of hepatitis B virus following systemic chemotherapy].
    Tanaka Y
    Rinsho Ketsueki; 2012 Oct; 53(10):1793-800. PubMed ID: 23037753
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prevention of hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy].
    Wang GQ
    Zhonghua Nei Ke Za Zhi; 2008 Oct; 47(10):796-7. PubMed ID: 19080131
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
    Lubel JS; Angus PW
    J Gastroenterol Hepatol; 2010 May; 25(5):864-71. PubMed ID: 20546439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.